SMTL ID : 8tui.1

Crystal structure of Fab-Lirilumab bound to KIR2DL3

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.75 Å
Oligo State
hetero-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN- NAG- MAN- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lorig-Roach, N. et al., Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab. Sci Rep (2024)
Release Date
2023-12-06
Peptides
Lirilumab Fab Heavy Chain: A
Lirilumab Fab Light chain: B
Killer cell immunoglobulin-like receptor 2DL3: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
H
B
L
C
A

Lirilumab Fab Heavy Chain

Lirilumab Fab Light chain

Killer cell immunoglobulin-like receptor 2DL3

Related Entries With Identical Sequence

1b6u.1